Approaches to prostate cancer by managed care organizations

Urology

Volumn 50, Issue 1, 1997, Pages 79-86

  Bennett, Charles L ^a   Buchner, Deborah A ^b   Ullman, Matthew ^b  

^a Lakeside VA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER PATIENT; CANCER SURGERY; COST CONTROL; HEALTH INSURANCE; HUMAN; MALE; MEDICAL DECISION MAKING; PRIORITY JOURNAL; PROSTATE CANCER;

HEALTH CARE SURVEYS; HUMANS; MALE; MANAGED CARE PROGRAMS; PROSTATIC NEOPLASMS; UNITED STATES;

EID: 0030857073     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(97)00239-2     Document Type: Article

References (33)

1. American Cancer Society: Cancer Facts and Figures - 1996. Atlanta, American Cancer Society, 1996.
2. Wilt TJ, and Drawer MK: Early intervention or expectant management for prostate cancer. PIVOT: a randomized trial comparing radical prostatectomy with expectant management for the treatment of clinically localized prostate cancer. Semin Urol 13: 130-136, 1995.
3. Wilt TJ, and Brawer MK: PIVOT: A randomized trial comparing prostatectomy versus expectant management for the treatment of clinically localized prostate cancer. J Urol 152: 1910-1914, 1994.
4. Whitmore WE Jr: Management of clinically localized prostate cancer: an unresolved problem. JAMA 269: 2676-2677, 1993.
5. Chodak GW, Thisted RA, Gerber GS, Johansson JE, Adolfsson J, Jones GW, Chisholm GD, Moskovitz B, Livne PM, Warner J, et al: Results of conservative management of clinically localized prostate cancer. N Engl J Med 330: 242-248, 1994.
6. Fleming C, Wasson JH, Albertson PC, Barry MJ, Wennberg JE, for the Prostate Patient Outcomes Research Team: A decision analysis of alternative treatment strategies for clinically localized prostate cancer. JAMA 269: 2650-2658, 1993.
7. Beard CJ, Propert KJ, Rieker PP, Clark JA, Kaplan I, Kantoff PW, and Talcott JA. Complications after treatment with external-beam irradiation in early-stage prostate cancer patients: a prospective multiinstitutional outcomes study. J Clin Oncol 15: 223-229, 1997.
8. Potosky AL, Miller BA, Albertsen PC, and Kramer BS. The role of increasing detection in the rising incidence of prostate cancer. JAMA 273: 548-552, 1995.
9. Lubke WL, Optenberg SA, and Thompson IM: Analysis of the first-year cost of a prostate cancer screening and treatment program in the United States. J Natl Cancer Inst 86: 1790-1792, 1994.
10. Kramer BS, Brown ML, Prorok PC, Potosky AL, and Gohagan JK: Prostate cancer screening: what we know and what we need to know. Ann Intern Med 119: 914-923, 1993.
11. Gee WF, Holtgrewe HL, Albertsen PC, Litwin MS, Manyak MJ, O'Leary MP, and Painter MR: Practice trends in the diagnosis and management of prostate cancer in the United States. J Urol 154: 207-208, 1995.
12. Middleton RG, Thompson IM, Austenfeld MS, Cooner WH, Correa RJ, Gibbons RP, Millee HC, Oesterling JE, and Resnick MI: Prostate cancer clinical guidelines panel summary report on the management of clinically localized prostate cancer. J Urol 154: 2144-2148, 1995.
13. National Cancer Institute: Consensus development conference on the management of clinically localized prostate cancer. NCI Monogr 7: 1-181, 1988.
14. Bennett CL, Matchar D, McCrory D, McLeod DG, Crawford ED, and Hillner BE: Cost-effective models for flutamide for prostate carcinoma patients: are they helpful to policy makers? Cancer 77: 1854-1861, 1996.
15. Handley MR, and Stuart ME: The use of PSA for prostate cancer screening: a managed care perspective. J Urol 152: 2689-2692, 1995.
16. Corrigan JM, and Nielsen DM: Toward the development of uniform reporting standards for managed care organizations: the Health Plan Employer Data and Information Set (Version 2.0). Joint CommJ Qual Improv 19: 566-575, 1993.
17. Ullman M, Metzger CK, Kuzel T, and Bennett CL: Performance measurement in prostate cancer care: beyond report cards. Urology 47: 356-365, 1996.
18. Albertsen PC, Fryback DG, Storer BE, Kohn TF, and Fine J: Long-term survival among men with conservatively treated localized prostate cancer. JAMA 274: 626-631, 1995.
19. Steinwachs DM, Wu AW, and Skinner EA: How will outcomes management work? Health Aff (Millwood) 13: 153-162, 1994.
20. Tougaard L, Krone T, Sorknaes A, Ellegaard H, for the PASTMA group: Economic benefits of teaching patients with chronic obstructive pulmonary disease about their illness. Lancet 339: 1517-1520, 1992.
21. Grampan Asthma Study of Integrated Care: Integrated care for asthma: a clinical, social, and economic evaluation. BMJ 308: 559-604, 1994.
22. Kaste M, Palomaki H, and Sarna S: Where and how should elderly stroke patients be treated? A randomized trial. Stroke 26: 249-253, 1995.
23. Epstein RS, and Sherwood LM: From outcomes research to disease management: a guide for the perplexed. Ann Intern Med 124: 832-837, 1996.
24. Harris JM Jr: Disease management: new wine in new bottles. Ann Intern Med 124: 838-842, 1996.
25. Berwick DM: Continuous improvement as an ideal in health care. N Engl J Med 320: 53-56, 1981.
26. Roper WL, Winkenwerder W, Hackbarth GM, and Krakauer H: Effectiveness in health care: an initiative to evaluate and improve medical practice. N Engl J Med 319: 1197-1202, 1988.
27. Guess HA, Jacobsen SJ, Girman CJ, Oesterling JE, Chute CG, Panser LA, and Lieber MM: The role of community based longitudinal studies in evaluating treatment effects. Example: benign prostatic hyperplasia. Med Care 33 (suppl 4): AS286-AS291, 1996.
28. Ellwood PM: Shattuck Lecture - outcomes management. A technology of patient experience. N Engl J Med 318: 1549-1556, 1988.
29. Mark DH: Mortality of patients after radical prostatectomy: analysis of recent Medicare claims. J Urol 152: 896-898, 1994.
30. Garnick MB: The dilemmas of prostate cancer. Sci Am 270: 72-81, 1994.
31. Lu-Yao GL, McLerran D, Wasson J, and Wennberg JE: An assessment of radical prostatectomy. Time trends: geographic variation and outcomes. JAMA 269: 2633-2636, 1993.
32. Barry MJ, Fowler FJ, Mulley A Jr, Henderson JV Jr, and Wennberg JE: Patient reaction to a program designed to facilitate patient participation in treatment decisions for benign prostatic hypertrophy. Med Care 33: 771-782, 1995.
33. Eddy DM: Clinical decision making: from theory to practice. The individual versus society. Resolving the conflict. JAMA 265: 2399-2401, 2405-2406, 1991.